仇凯

仇凯 is a declared insider of 伟思医疗 (senior executive), with filings sourced from SSE / SZSE (CSRC). Between 26 April 2023 and 5 June 2025, the trades on record add up to 3 filings.

No open-market purchase appears, only 3 sales worth €134k. In 2025 alone, the filings show no purchases and 2 sales.

The latest filing, published on 5 June 2025, reports an open-market sale of €67k in 伟思医疗. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.